Skinhealth Systems Inc. (SKIN) — SEC Filings
Skinhealth Systems Inc. (SKIN) — 42 SEC filings. Latest: 8-K (Apr 22, 2026). Includes 15 8-K, 12 SC 13G/A, 6 10-Q.
View Skinhealth Systems Inc. on SEC EDGAR
Overview
Skinhealth Systems Inc. (SKIN) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 22, 2026: SkinHealth Systems Inc. filed an 8-K on April 22, 2026, reporting changes in its corporate structure and bylaws. The filing includes amendments to its articles of incorporation and bylaws, as well as a corporate rebrand presentation and a press release dated April 22, 2026. The company also disclose
Sentiment Summary
Across 42 filings, the sentiment breakdown is: 1 bearish, 40 neutral, 1 mixed. The dominant filing sentiment for Skinhealth Systems Inc. is neutral.
Filing Type Overview
Skinhealth Systems Inc. (SKIN) has filed 1 4, 15 8-K, 6 10-Q, 2 8-K/A, 2 DEF 14A, 2 10-K, 12 SC 13G/A, 1 SC 13G, 1 SC 13D/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (42)
Risk Profile
Risk Assessment: Of SKIN's 29 recent filings, 1 were flagged as high-risk, 19 as medium-risk, and 9 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $70.655M |
| Net Income | -$11.031M |
| EPS | N/A |
| Debt-to-Equity | 6.67 |
| Cash Position | $219.397M |
| Operating Margin | -8.84% |
| Total Assets | $503.636M |
| Total Debt | $363.388M |
Key Executives
- Clinton Carnell
- Brenton Saunders
- Andrew Stanleick
- Marla Beck
- Andrew D. Staniforth
- Andrew C. Chang
- Dr. Vivian Lee
- Michael J. Moschner
- Dr. Jessica Wu
- Ms. Michelle Freidman
- Marisa Plescia
- Michael Moskowitz
- Robert B. McKeon
- Michael J. Nolan
- Brenton L. Saunders
Industry Context
The beauty and wellness industry is characterized by intense competition, rapid innovation, and evolving consumer preferences. Companies like Beauty Health Co. face pressure from established global brands, agile direct-to-consumer startups, and a growing demand for personalized and technologically advanced treatments. The market is also influenced by trends in sustainability, ingredient transparency, and digital engagement.
Top Tags
corporate-governance (6) · executive-compensation (6) · amendment (5) · financials (4) · 10-Q (4) · material-agreement (3) · filing-update (2) · Beauty Industry (2) · Revenue Decline (2) · filing (2)
Executive Compensation
From the most recent DEF 14A filing (Apr 26, 2024):
- Clinton Carnell — Member
- Brenton L. Saunders — Member
- Andrew Stanleick — Member
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net sales for Q3 2025 | $70.655M | Decreased from $78.802 million in Q3 2024 |
| Net sales for YTD Q3 2025 | $218.422M | Decreased from $250.799 million in YTD Q3 2024 |
| Net loss for Q3 2025 | $11.031M | Improved from $18.291 million net loss in Q3 2024 |
| Net loss for YTD Q3 2025 | $1.415M | Significantly improved from $18.768 million net loss in YTD Q3 2024 |
| Gross profit for Q3 2025 | $45.634M | Increased from $40.649 million in Q3 2024 |
| Gross profit for YTD Q3 2025 | $143.326M | Increased from $129.950 million in YTD Q3 2024 |
| Cash, cash equivalents, and restricted cash at Sep 30, 2025 | $219.397M | Decreased from $370.063 million at Dec 31, 2024 |
| Aggregate principal amount of 2026 Notes exchanged and repurchased | $413.2M | Part of debt restructuring in May 2025 |
| Principal amount of new 7.95% Convertible Senior Secured Notes due 2028 | $250.0M | Issued in May 2025 as part of debt exchange |
| Interest rate on 2028 Convertible Senior Secured Notes | 7.95% | Higher interest rate compared to 1.25% on 2026 Notes |
| SEC File Number | 001-39565 | Identifies the company's filing with the SEC |
| IRS Employer Identification No. | 85-1908962 | Company's tax identification number |
| Q2 2025 Revenue | $80.5M | 31.4% decrease from Q2 2024 |
| Q2 2025 Net Loss | $45.2M | Widened from $15.8M in Q2 2024 |
| Q2 2025 Loss Per Share | $0.34 | Increased from $0.12 in Q2 2024 |
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Skinhealth Systems Inc. (SKIN)?
Skinhealth Systems Inc. has 42 recent SEC filings from Jan 2024 to Apr 2026, including 15 8-K, 12 SC 13G/A, 6 10-Q. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of SKIN filings?
Across 42 filings, the sentiment breakdown is: 1 bearish, 40 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Skinhealth Systems Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Skinhealth Systems Inc. (SKIN) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Skinhealth Systems Inc.?
Key financial highlights from Skinhealth Systems Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for SKIN?
The investment thesis for SKIN includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Skinhealth Systems Inc.?
Key executives identified across Skinhealth Systems Inc.'s filings include Clinton Carnell, Brenton Saunders, Andrew Stanleick, Marla Beck, Andrew D. Staniforth and 15 others.
What are the main risk factors for Skinhealth Systems Inc. stock?
Of SKIN's 29 assessed filings, 1 were flagged high-risk, 19 medium-risk, and 9 low-risk.
What are recent predictions and forward guidance from Skinhealth Systems Inc.?
Forward guidance and predictions for Skinhealth Systems Inc. are extracted from SEC filings as they are enriched.